Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2008
11/13/2008WO2008136377A1 Bicyclic heterocyclic compound
11/13/2008WO2008135578A1 Pyrazolo [3, 4-d] pyrimidine derivatives for the treatment of inflammation and/or allergic conditions
11/13/2008WO2008135537A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/13/2008WO2008135526A1 Carboxylic acid amides as factor xa inhibitors
11/13/2008WO2008135442A1 Heterocyclic compounds and their use as pesticides
11/13/2008WO2008135141A1 2 -heteroaryl- pyrrolo [3, 4-c] pyrrole derivatives and their use as scd inhibitors
11/13/2008WO2008118454A3 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
11/13/2008WO2008113469A3 Substituted imidazopyrimidines and triazolopyrimidines
11/13/2008WO2008094602A3 1-h-pyrazolo (3,4b) pyrimidine derivatives and their use as modulators of mitotic kinases
11/13/2008WO2008078100A3 Tricyclic amine derivatives as protein tyrosine kinase inhibitors
11/13/2008WO2008028168A3 Serine-threonine protein kinase and parp modulators
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008WO2007147109A3 Novel compounds
11/13/2008WO2007133560A9 Acetylenic heteroaryl compounds
11/13/2008US20080281100 Purification
11/13/2008US20080281097 Process for Preparing an Angiotensin II Receptor Antagonist
11/13/2008US20080281091 Process for the Preparation of Porphyrin Derivatives as Antimicrobial Agents by Photodynamic Therapy (Pdt)
11/13/2008US20080280933 Benzimidazolyl compounds
11/13/2008US20080280928 Pyrrolopyrimidine and Pyrrolopyridine Derivatives Substituted with a Cyclic Amino Group As Crf Antagonists
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/13/2008US20080280907 Triazolophthalazines
11/13/2008US20080280899 Cancer; such as 3-({4-[2-(methylthio)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]benzyl}amino)-1-phenylpropan-1-one; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity
11/13/2008US20080280895 5-Amino-4-Hydroxy-7-(1H-Indolmethyl)-8-Methylnonamide Derivatives as Renin Inhibitors for the Treatment of Hypertension
11/13/2008US20080280882 Novel Substituted Diazabicyclo Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
11/13/2008US20080280876 Sphingosine-1-phosphate (S1P) receptor agonists or antagonists; immunosuppressants; e.g. 3-(3-chloro-4-isopropoxyphenyl)-5-(p-(3-carboxyazetidin-1-ylmethyl)phenyl)-1,2,4-oxadiazole; two specific compounds are excluded
11/13/2008US20080280872 Benzamide Derivatives and Their Use as Glucokinase Activating Agents
11/13/2008US20080280759 6-(2-Fluoro-4-Alkoxyphenyl) Triazolopyrimidines, Their Preparation, Their Use For Controlling Harmful Fungi, and Compositions Comprising Them
11/13/2008US20080280334 Method for Preparing 3-Hydroxy-4-Hydroxymethyl-Pyrrolidine Compounds
11/13/2008US20080279950 Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof
11/13/2008US20080279821 Arylpiperidinyl and arylpyrrolidinyl macrocyclic hepatitis c serine protease inhibitors
11/13/2008US20080277649 Field Effect Transistor and Method of Producing Same
11/13/2008DE112005003752T5 Neues Pyrrolo[2,1-c][1,4]benzodiapezinhybrid und ein Verfahren zu dessen Herstellung New pyrrolo [2,1-c] [1,4] benzodiapezinhybrid and a process for its preparation
11/13/2008CA2686707A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008CA2686138A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/13/2008CA2685543A1 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd inhibitors
11/13/2008CA2683821A1 Heterocyclic compounds and their use as pesticides
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1989207A1 Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol
11/12/2008EP1989205A2 Thiophene-carboxamides useful as inhibitors of protein kinases
11/12/2008EP1989201A1 Pi-3 kinase inhibitors and methods of their use
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1587806B1 Pyrimido 5,4-e 1,2,4 triazine-5,7-diones, methods for producing the same and their use
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008EP1261607B1 2,4-disubstituted thiazolyl derivatives
11/12/2008CN101305057A Method of producing a metal phthalocyanine compound, and method of producing a phthalocyanine compound and an analogue thereof
11/12/2008CN101305011A Pyridine derivatives and their use in the treatment of psychotic disorders
11/12/2008CN101305008A Tetracyclic indole derivatives as antiviral agents
11/12/2008CN101305007A Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors
11/12/2008CN101305006A Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
11/12/2008CN101305005A Novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases
11/12/2008CN101304997A Bridged N-bicyclic sulfonamido inhibitors of gamma secretase
11/12/2008CN101302219A Fluorene derivative containing large conjugated molecule and preparation thereof
11/12/2008CN101302218A Preparation of Trandolapril diketone
11/12/2008CN100432075C Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
11/12/2008CN100432074C Method for synthesizeing aryl imidazo [2, 1 a] isoquinoline
11/11/2008US7450293 Electrochromic salts, solutions, and devices
11/11/2008US7449585 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449489 e.g. isopropyl [({2-[5-[2-(2-azabicyclo[2.2.2]oct-2-yl)- 1,1-dimethyl-2-oxoethyl]-2-(3,5-dimethylphenyl)-1H-indol-3-yl]propyl }amino)(3-pyridin-4-ylpyrrolidin-1-yl)methylene]carbamate; gonadotrophin releasing hormone antagonists; anticarcinogenic agent; breast, prostate, uretus cancer
11/11/2008US7449488 Pyrazolopyrimidines as protein kinase inhibitors
11/11/2008US7449476 e.g. 2,3,4,5-tetrahydro-2-[2-[4-methoxy-7-(5-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-5-phenyl-1H-pyrido[4,3-b]indole; inhibit HIV entry by attaching to exterior viral envelop protein gp120 and interrupting viral entry process by interfering with cellular receptor CD4
11/11/2008US7449473 8-(1-methyl-1H-pyrrol-2-yl)-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidine-2,6-dione; asthma, chronic obstructive pulmonary disorder, emphysema, diabetic disorders, inflammatory gastrointestinal tract disorders, immunological/inflammatory disorders, cardiovascular diseases, neurological disorders
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449465 glycogen synthase kinase 3 alpha and 3 beta inhibitors; improved phanrmacological activity, potency, selectivity, solubility, permeability, metabolic stability; bipolar disorder; Alzheimer's disease; type II diabetes, neuropathic pain; depression; inflammatory diseases
11/11/2008US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/11/2008US7449454 Metallotexaphyrin derivatives
11/11/2008US7449175 Delivery of erectile dysfunction drugs through an inhalation route
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/06/2008WO2008134690A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/06/2008WO2008134036A1 ALPHA-SUBSTITUTED ARYLMETHYL PIPERAZINE PYRAZOLO[1,5-α]PYRIMIDINE AMIDE DERIVATIVES
11/06/2008WO2008134035A1 Alpha-unsubstituted arylmethyl piperazine pyrazolo[1,5-a] pyrimidine amide derivatives
11/06/2008WO2008133866A1 Polymorph of dihydropyrazolopyrimidinone derivative as weel kinase.inhibitor
11/06/2008WO2008133664A2 Carboranylporphyrins and uses thereof
11/06/2008WO2008133274A1 Aminodihydrothiazine derivatives substituted with cyclic groups
11/06/2008WO2008133192A1 Fused imidazole compound and use thereof
11/06/2008WO2008132433A1 Fluorinated lanthanide probes for 19f magnetic resonance applications
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008070358A3 N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain
11/06/2008US20080275235 Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors
11/06/2008US20080275232 contacting meso-(2'-hydroxymethyl)phenyl porphyrin or meso-(2'-N,N,N-trialkylaminomethyl)phenyl porphyrin precursors with acid catalysts for a sufficient time to yield the desired conversion to naphthochlorin compounds, used for tissue-targeted therapy
11/06/2008US20080275078 Pyrazolo[3,4-B] Pyridine Compounds and Their Use as Pde4 Inhibitors
11/06/2008US20080275067 5-methyl-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; 3-(4-fluoro-phenyl)-5-methyl-2-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ethyl]-3H-quinazolin-4-one; bone-resorption disorder or a cancer of a hematopoietic origin; disorders in which PI3K plays a role in leukocyte function
11/06/2008US20080275065 insecticide for representatives of the order Acarina; protection of plant propagation material from the attack by pests; N-(4-chloro-2-methyl-6-[([oxetan-2-ylmethyl]amino)carbonyl]phenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275054 3-(Substituted Amino)-Pyrazolo[3, 4-D]Pyrimidines as Ephb and Vegfr2 Kinase Inhibitors
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275051 Preparation of High Purity Substituted Quinoxalines
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
11/06/2008US20080275026 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/06/2008US20080274080 Aza-peptide macrocyclic hepatitis c serine protease inhibitors
11/06/2008CA2685524A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/06/2008CA2683887A1 Aminodihydrothiazine derivatives substituted with a cyclic group
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1987039A2 Melanin concentrating hormone receptor-1 antagonists
11/05/2008EP1987038A2 Hcv ns5b inhibitors
11/05/2008EP1987037A2 Fused heterocyclic compound
1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 573